- Latest Deal Type
Biomeostatis General Information
Operator of a research organization intended to excel in the field of nutritional behavior and related metabolic disorders. The company provides primary and secondary pharmacodynamic studies on relevant healthy and pathophysiological rodent models to evaluate and anticipate the efficacy, safety, and mode of action for novel drugs and nutraceuticals targeting nutritional behavior and related metabolic disorders, enabling healthcare professionals to tackle diseases.
Privately Held (backing)
Other Healthcare Technology Systems
Other Healthcare Services
- Ave Escadrille Normandie Niémen
- 13397 Marseille
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Biomeostatis Valuation & Funding
|Deal Type||Date||Amount||Raised to Date||Post-Val||Status||Stage|
Biomeostatis Executive Team (2)
|Name||Title||Board Seat||Contact Info|
|Bruno Bariohay Ph.D||Co-Founder & Chief Executive Officer|
|Julien Roux Ph.D||Co-Founder & Chief Scientific Officer|
Biomeostatis Investors (1)
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|
|Incubateur Impulse||Accelerator/Incubator||000 0000||000000 0|